These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30284855)

  • 1. Risk of progression to Alzheimer's disease for different neuropsychological Mild Cognitive Impairment subtypes: A hierarchical meta-analysis of longitudinal studies.
    Oltra-Cucarella J; Ferrer-Cascales R; Alegret M; Gasparini R; Díaz-Ortiz LM; Ríos R; Martínez-Nogueras ÁL; Onandia I; Pérez-Vicente JA; Cabello-Rodríguez L; Sánchez-SanSegundo M
    Psychol Aging; 2018 Nov; 33(7):1007-1021. PubMed ID: 30284855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray matter atrophy patterns of mild cognitive impairment subtypes.
    Zhang H; Sachdev PS; Wen W; Kochan NA; Crawford JD; Brodaty H; Slavin MJ; Reppermund S; Draper B; Zhu W; Kang K; Trollor JN
    J Neurol Sci; 2012 Apr; 315(1-2):26-32. PubMed ID: 22280946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia.
    Jungwirth S; Zehetmayer S; Hinterberger M; Tragl KH; Fischer P
    Int Psychogeriatr; 2012 Jun; 24(6):959-66. PubMed ID: 22300486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Verbal Fluency Strategies among Individuals with Normal Cognition, Amnestic and Non-Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Bairami S; Folia V; Liampas I; Ntanasi E; Patrikelis P; Siokas V; Yannakoulia M; Sakka P; Hadjigeorgiou G; Scarmeas N; Dardiotis E; Kosmidis MH
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893577
    [No Abstract]   [Full Text] [Related]  

  • 8. Language Differences Among Individuals with Normal Cognition, Amnestic and Non-Amnestic MCI, and Alzheimer's Disease.
    Liampas I; Folia V; Morfakidou R; Siokas V; Yannakoulia M; Sakka P; Scarmeas N; Hadjigeorgiou G; Dardiotis E; Kosmidis MH
    Arch Clin Neuropsychol; 2023 May; 38(4):525-536. PubMed ID: 36244060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI.
    Putcha D; Tremont G
    J Clin Exp Neuropsychol; 2016 Nov; 38(9):991-1004. PubMed ID: 27240585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of diabetes with amnestic and nonamnestic mild cognitive impairment.
    Roberts RO; Knopman DS; Geda YE; Cha RH; Pankratz VS; Baertlein L; Boeve BF; Tangalos EG; Ivnik RJ; Mielke MM; Petersen RC
    Alzheimers Dement; 2014 Jan; 10(1):18-26. PubMed ID: 23562428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved.
    Espinosa A; Alegret M; Valero S; Vinyes-Junqué G; Hernández I; Mauleón A; Rosende-Roca M; Ruiz A; López O; Tárraga L; Boada M
    J Alzheimers Dis; 2013; 34(3):769-80. PubMed ID: 23271318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Mild Cognitive Impairment and Its Subtypes among Chinese Older Adults: Role of Vascular Risk Factors.
    Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
    Dement Geriatr Cogn Disord; 2016; 41(5-6):261-72. PubMed ID: 27304680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
    Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
    Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid cerebral amyloid angiopathy in dementia and prodromal stages-Prevalence and effects on cognition.
    Haussmann R; Homeyer P; Sauer C; Grey A; Krukowski P; Brandt MD; Donix M; Linn J
    Int J Geriatr Psychiatry; 2023 Oct; 38(10):e6015. PubMed ID: 37847104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
    Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
    BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Patterns and Clinical Implications of Semantic Memory Deterioration Among Patients With MCI.
    Chang HT; Chiu MJ; Chen TF; Cheng TW; Hua MS
    Alzheimer Dis Assoc Disord; 2015; 29(2):124-34. PubMed ID: 25187221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.